Brazzelli V, Barbagallo T, Prestinari F, Rona C, De Silvestri A, Trevisan V, Borroni G
Department of Human and Hereditary Pathology, Institute of Dermatology, University of Pavia, Italy.
Int J Immunopathol Pharmacol. 2005 Oct-Dec;18(4):755-60. doi: 10.1177/039463200501800419.
Photochemotherapy with psoralen plus ultraviolet A(PUVA) and phototherapy with UVB narrow band (UVB-NB) are used in the treatment of psoriasis. Numerous studies have shown that the additional administration of either topical or systemic antipsoriatic agents may effectively increase the efficacy of these therapies. This study aimed to compare through objective data the efficacy of topical tacalcitol in combination with PUVA or UVB-NB versus PUVA and UVB-NB monotherapy in the treatment of mild to moderate chronic plaque psoriasis. Modified Psoriasis Area and Severity Index (PASI) score, transepidermal water loss (TEWL) and stratum corneum hydration were used to monitor the restoration of skin barrier in the psoriatic plaques of 40 patients during photochemotherapy. The study was a right-left, intra-individual, pre/post comparison trial. PUVAand UVB-NB treatments were given three times a week. On those plaques localized on the right side of the body tacalcitol ointment was applied once a day, in the evening. Corneometry, TEWL and modified PASI score were used to evaluate the response to the treatment at baseline, one month and two months. Thirty-six of the forty enrolled subjects completed the study. The comparison between combination treatments and the PUVA/UVB-NB monotherapy showed no significant differences with regard to modified PASI index. However, significant differences were recorded with regard to TEWL and corneometry. The combination of tacalcitol plus PUVA or tacalcitol plus UVB-NB restored epidermal barrier functions as well as skin hydration faster than PUVA or UVB-NB monotherapy (TEWL: p=0.0050 and corneometry: p=0.003). The combination of tacalcitol plus UVB-NB allowed a better restoration of skin barrier functions than tacalcitol plus PUVA (p=0.013). In conclusion, the combination of tacalcitol plus PUVA or plus UVB-NB improves the therapeutic result. In addition, the data from TEWL and skin hydration suggest a means in which tacalcitol plus UVB-NB induces a better normalization of skin biophysical parameters.
补骨脂素加紫外线A(PUVA)光化学疗法和窄谱中波紫外线(UVB-NB)光疗用于治疗银屑病。大量研究表明,额外给予局部或全身性抗银屑病药物可有效提高这些疗法的疗效。本研究旨在通过客观数据比较局部用他卡西醇联合PUVA或UVB-NB与PUVA和UVB-NB单一疗法治疗轻度至中度慢性斑块状银屑病的疗效。采用改良银屑病面积和严重程度指数(PASI)评分、经表皮水分流失(TEWL)和角质层水合作用来监测40例患者在光化学疗法期间银屑病斑块皮肤屏障的恢复情况。该研究为左右侧、个体内、治疗前后比较试验。PUVA和UVB-NB治疗每周进行3次。对于位于身体右侧的那些斑块,每天晚上涂抹一次他卡西醇软膏。使用角质层测厚仪、TEWL和改良PASI评分在基线、1个月和2个月时评估对治疗的反应。40名入选受试者中有36名完成了研究。联合治疗与PUVA/UVB-NB单一疗法之间在改良PASI指数方面无显著差异。然而,在TEWL和角质层测厚方面记录到显著差异。他卡西醇加PUVA或他卡西醇加UVB-NB联合使用比PUVA或UVB-NB单一疗法更快地恢复了表皮屏障功能以及皮肤水合作用(TEWL:p = 0.0050,角质层测厚:p = 0.003)。他卡西醇加UVB-NB联合使用比他卡西醇加PUVA能更好地恢复皮肤屏障功能(p = 0.013)。总之,他卡西醇加PUVA或加UVB-NB联合使用可改善治疗效果。此外,TEWL和皮肤水合作用的数据表明他卡西醇加UVB-NB能使皮肤生物物理参数更好地恢复正常。